Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 158

Sort by

Sort Order Select

Journal Articles

Immune and Myeloid Differentiation Shape Transcriptome to Discriminate Evolutionary Stages of Cellular Transformation

Lacey Scott Williams, Anne S. S. Renteria, Maher Albitar, Gustavo A. Rivero

Blood (2024) 144 (Supplement 1): 2923.

https://doi.org/10.1182/blood-2024-211159

Published: 2024

Journal Articles

Clonotype-Naïve Detection of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA)

Maher Albitar, Hong Zhang, Sally Agersborg, Ahmad Charifa, Pooja Phull, Noa Biran, David H. Vesole, Harsh Parmar, Andrew L Pecora, Andrew Ip, Andre Goy, David S. Siegel

Blood (2024) 144 (Supplement 1): 1946.

https://doi.org/10.1182/blood-2024-201810

Published: 2024

Journal Articles

Establishing a Distinct Cytokine Signature for Multiple Myeloma Using Bone Marrow RNA and Peripheral Blood Cell-Free RNA (cfRNA)

Maher Albitar, Hong Zhang, Sally Agersborg, Ahmad Charifa, Pooja Phull, Noa Biran, David H. Vesole, Harsh Parmar, Andrew L Pecora, Andrew Ip, Andre Goy, David S. Siegel

Blood (2024) 144 (Supplement 1): 3316.

https://doi.org/10.1182/blood-2024-203774

Published: 2024

Journal Articles

Establishing Lymphoma Type-Specific Cytokine Signatures Using Tissue-Based RNA or Peripheral Blood Cell-Free RNA (cfRNA)

Maher Albitar, Hong Zhang, Sally Agersborg, Ahmad Charifa, Andrew L Pecora, Lori A. Leslie, Tatyana Feldman, Andrew Ip, Andre Goy

Blood (2024) 144 (Supplement 1): 4367.

https://doi.org/10.1182/blood-2024-203834

Published: 2024

Journal Articles

Establishing Distinct Cytokine Signatures Differentiating between Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Chip Using Bone Marrow RNA or Cell-Free RNA (cfRNA)

Maher Albitar, Sally Agersborg, Ahmad Charifa, Hong Zhang, Andrew Ip, Katherine Linder, Andrew L Pecora, Jamie Koprivnikar, Andre Goy, James McCloskey

Blood (2024) 144 (Supplement 1): 4295.

https://doi.org/10.1182/blood-2024-203870

Published: 2024

Journal Articles

Identifying Clinical and Deregulated Genomic Pathways for Phenotypic Leukostasis in Newly Diagnosed Acute Myelogenous Leukemia

Rachel Zemel, Vincent Cendan, Erika Foerst, Lacey Scott Williams, Hafsa Bhatty, Maher Albitar, Anne S. S. Renteria, Gustavo A. Rivero

Blood (2024) 144 (Supplement 1): 6113.

https://doi.org/10.1182/blood-2024-208696

Published: 2024

Journal Articles

Parallel Immunotranscriptomic and Immunohistochemistry Enhance Cluster Discrimination in Acute Myelogenous Leukemia

Olivia Wilkins, Munther Hammad, Megan Clyne, Audrey Huelskamp, Hafsa Bhatty, Ali Firozvi, Alexandra Thalberg, Lacey Scott Williams, Anne S. S. Renteria, Maher Albitar, Gustavo A. Rivero

Blood (2024) 144 (Supplement 1): 6155.

https://doi.org/10.1182/blood-2024-211411

Published: 2024

Journal Articles

Clearance of Circulating Multiple Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

Blood (2024) 144 (Supplement 1): 4687.

https://doi.org/10.1182/blood-2024-209181

Published: 2024

Journal Articles

Polygenic HLA-Class I and HLA-Class II Models Define Various Types of Lymphoma

Maher Albitar, Hong Zhang, Andrew Ip, Gustavo A. Rivero, Wanlong Ma, Jeffrey Justin Estella, Lori A. Leslie, Tatyana Feldman, Ahmad Charifa, Arash Mohtashamian, Andrew L Pecora, Andre Goy

Blood (2023) 142 (Supplement 1): 6110.

https://doi.org/10.1182/blood-2023-187686

Published: 2023

Journal Articles

Deregulation of HLA-Class I and Class II Genes in Chip, MDS, and Acute Leukemia and Similarity between Chip and MDS in HLA Profile

Maher Albitar, Hong Zhang, Andrew Ip, Gustavo A. Rivero, Wanlong Ma, James McCloskey, Katherine Linder, Jeffrey Justin Estella, Jamie Koprivnikar, Ahmad Charifa, Arash Mohtashamian, Andrew L Pecora, Andre Goy

Blood (2023) 142 (Supplement 1): 5688.

https://doi.org/10.1182/blood-2023-187606

Published: 2023

Journal Articles

Using Next Generation Sequencing of Flow Cytometry CD Markers and Machine Learning As a Replacement to Flow Cytometry Analysis for the Diagnosis of Hematologic Neoplasms

Maher Albitar, Hong Zhang, Andrew Ip, Wanlong Ma, James McCloskey, Katherine Linder, Jeffrey Justin Estella, Jamie Koprivnikar, Noa Biran, David S. Siegel, Ahmad Charifa, Arash Mohtashamian, Andrew L Pecora, Andre Goy

Blood (2023) 142 (Supplement 1): 3654.

https://doi.org/10.1182/blood-2023-187041

Published: 2023

Journal Articles

Lymphoma Diagnosis and Classification Using Next Generation Sequencing of 30 CD Markers and Machine Learning As an Alternative to Immunohistochemistry

Maher Albitar, Hong Zhang, Andrew Ip, Wanlong Ma, Jeffrey Justin Estella, Lori A. Leslie, Tatyana Feldman, Ahmad Charifa, Arash Mohtashamian, Andrew L Pecora, Andre Goy

Blood (2023) 142 (Supplement 1): 3665.

https://doi.org/10.1182/blood-2023-187534

Published: 2023

Journal Articles

Disparities in Somatic Mutations and Outcomes in Primary Central Nervous System Lymphoma Comparing Patients of Hispanic and Non-Hispanic Ethnicity

Haifaa Abdulhaq, Omar Mahmood, Calvin Kuan Jung Chen, Azra Borogovac, Matthew Wieduwilt, Anand Annan, Yueqi Yan, Maher Albitar

Blood (2022) 140 (Supplement 1): 3553–3554.

https://doi.org/10.1182/blood-2022-164902

Published: 2022

Journal Articles

Liquid Immunophenotyping and the Diagnosis of Lymphoid Neoplasms Using Cell-Free RNA

Maher Albitar, Hong Zhang, Andrew Ip, Jeffrey Justin Estella, Ahmad Charifa, Wanlong Ma, Ipsa Sharma, Andrew L. Pecora, Lori Leslie, Tatyana Feldman, Andre H. Goy

Blood (2022) 140 (Supplement 1): 7828–7829.

https://doi.org/10.1182/blood-2022-162590

Published: 2022

Journal Articles

DNA and RNA Profiles in Machine Learning Algorithm to Predict Which Patients with AML/MDS Will Respond to Venetoclax-Based Therapy

Maher Albitar, Andrew Ip, Andre H. Goy, Katherine Linder, Jeffrey Justin Estella, Ahmad Charifa, Wanlong Ma, Andrew L. Pecora, Jamie Koprivnikar, James McCloskey

Blood (2022) 140 (Supplement 1): 6270–6271.

https://doi.org/10.1182/blood-2022-167406

Published: 2022

Journal Articles

Dose-Intense Frontline Chemotherapy Changes Molecular Classifier Prognostication in Diffuse Large B-Cell Lymphoma(DLBCL)

Tatyana Feldman, Maher Albitar, Hong Cheng, Kar Chow, Alessandra Petrillo, Ahmetmursel Ulusan, Andrew Ip, Alexandra Della Pia, Gabriella Magarelli, Brittany Lukasik, Lori Leslie, Pritish K. Bhattacharyya, Andrew L. Pecora, Andre H. Goy

Blood (2022) 140 (Supplement 1): 11893–11895.

https://doi.org/10.1182/blood-2022-169586

Published: 2022

Journal Articles

Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Gvhd (aGVHD) and Overall Survival after Allogeneic HSC Transplantation

Maher Albitar, Hong Zhang, Andrew L. Pecora, Andrew Ip, Andre H. Goy, Spiraggelos Antzoulatos, Wanlong Ma, Sukhdeep Kaur, Hyung C. Suh, Michele L. Donato, Scott D. Rowley

Blood (2022) 140 (Supplement 1): 4757–4758.

https://doi.org/10.1182/blood-2022-162816

Published: 2022

Journal Articles

TP53 and MYD88 Mutations As Detected By Liquid Biopsy in the Prediction of Progression-Free Survival in Patients with Diffuse Large B-Cell Lymphoma

Maher Albitar, Andrew Ip, Hong Zhang, Andrew L. Pecora, Jeffrey Justin Estella, Ivan De Dios, Wanlong Ma, Lori A. Leslie, Tatyana A. Feldman, Andre H. Goy

Blood (2021) 138 (Supplement 1): 4480.

https://doi.org/10.1182/blood-2021-148122

Published: 2021

Journal Articles

Reliability of Cell-Free DNA (cfDNA) Next Generation Sequencing in Predicting Chromosomal Structural Abnormalities and Cytogenetic-Risk Stratification of Patients with Myeloid Neoplasms

Maher Albitar, Andrew Ip, Andre H. Goy, Jeffrey Justin Estella, Ivan De Dios, Wanlong Ma, Andrew L. Pecora, Jamie Koprivnikar, James K McCloskey

Blood (2021) 138 (Supplement 1): 3463.

https://doi.org/10.1182/blood-2021-148164

Published: 2021

Journal Articles

Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms

Blood (2021) 138 (Supplement 1): 2395.

https://doi.org/10.1182/blood-2021-148841

Published: 2021

NARROW

Immune and Myeloid Differentiation Shape Transcriptome to Discriminate Evolutionary Stages of Cellular Transformation

Clonotype-Naïve Detection of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA)

Establishing a Distinct Cytokine Signature for Multiple Myeloma Using Bone Marrow RNA and Peripheral Blood Cell-Free RNA (cfRNA)

Establishing Lymphoma Type-Specific Cytokine Signatures Using Tissue-Based RNA or Peripheral Blood Cell-Free RNA (cfRNA)

Establishing Distinct Cytokine Signatures Differentiating between Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Chip Using Bone Marrow RNA or Cell-Free RNA (cfRNA)

Identifying Clinical and Deregulated Genomic Pathways for Phenotypic Leukostasis in Newly Diagnosed Acute Myelogenous Leukemia

Parallel Immunotranscriptomic and Immunohistochemistry Enhance Cluster Discrimination in Acute Myelogenous Leukemia

Clearance of Circulating Multiple Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

Polygenic HLA-Class I and HLA-Class II Models Define Various Types of Lymphoma

Deregulation of HLA-Class I and Class II Genes in Chip, MDS, and Acute Leukemia and Similarity between Chip and MDS in HLA Profile

Using Next Generation Sequencing of Flow Cytometry CD Markers and Machine Learning As a Replacement to Flow Cytometry Analysis for the Diagnosis of Hematologic Neoplasms

Lymphoma Diagnosis and Classification Using Next Generation Sequencing of 30 CD Markers and Machine Learning As an Alternative to Immunohistochemistry

Disparities in Somatic Mutations and Outcomes in Primary Central Nervous System Lymphoma Comparing Patients of Hispanic and Non-Hispanic Ethnicity

Liquid Immunophenotyping and the Diagnosis of Lymphoid Neoplasms Using Cell-Free RNA

DNA and RNA Profiles in Machine Learning Algorithm to Predict Which Patients with AML/MDS Will Respond to Venetoclax-Based Therapy

Dose-Intense Frontline Chemotherapy Changes Molecular Classifier Prognostication in Diffuse Large B-Cell Lymphoma(DLBCL)

Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Gvhd (aGVHD) and Overall Survival after Allogeneic HSC Transplantation

TP53 and MYD88 Mutations As Detected By Liquid Biopsy in the Prediction of Progression-Free Survival in Patients with Diffuse Large B-Cell Lymphoma

Reliability of Cell-Free DNA (cfDNA) Next Generation Sequencing in Predicting Chromosomal Structural Abnormalities and Cytogenetic-Risk Stratification of Patients with Myeloid Neoplasms

Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only